Adipotide vs Tirzepatide
Updated 6 sources
Key differences
- 1Tirzepatide is an approved GLP-1/GIP drug with human data. Adipotide is a preclinical-stage vascular-targeting peptide.
- 2Community users who take both describe adipotide as a short add-on, not a replacement.
Side by side
Facts from each record, in the same words as their own pages.
| Adipotide | Tirzepatide | |
|---|---|---|
| Category |
|
|
| Evidence |
|
|
| FDA status |
|
|
| WADA |
|
|
| Half-life | Not reported |
|
| Routes |
|
|
| Forms |
| Not reported |
| Reported doses |
|
|
| Most cited frequency |
|
|
| Vial sizes |
|
|
| Mixed vial keeps |
|
|
| Protocols on file |
|
|
Doses shown are what sources report, labelled by origin. Not medical advice.
Read each in full
Sources
6 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.
Regulatory4
- Mounjaro and Mounjaro KwikPen label, rev. 8/2026DailyMed · checked Oct 24, 2026
- Zepbound Prescribing Information, rev. 04/2026FDA · checked Oct 24, 2026
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A (updated May 14, 2026)FDA · checked Oct 24, 2026
- Certain Bulk Drug Substances for Use in Compounding May Present Significant Safety RisksFDA · checked Oct 24, 2026
Community-reported2
- Comment: 1 mg for a day or two, then 3 mg a day for 28 daysReddit r/PeptideDiscussion · checked Oct 24, 2026
- Adipotide: community protocols and reportspeptideprotocolwiki.com, via a competitor guide · checked Oct 24, 2026